Bjorn Pasternak

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 120 publications

Glucagon-like Peptide-1 Receptor Agonists and Risk for Anterior Ischemic Optic Neuropathy : A Nationwide Cohort Study.

Glucagon-like Peptide-1 Receptor Agonists and Risk for Anterior Ischemic Optic Neuropathy : A Nationwide Cohort Study.

Journal: Annals of internal medicine

Published: July 13, 2026

Acute heart failure diagnosis and vasodilator use in a nationwide registry study: reply.

Acute heart failure diagnosis and vasodilator use in a nationwide registry study: reply.

Journal: European heart journal. Acute cardiovascular care

Published: June 09, 2026

Sedatives in pregnancy and psychiatric outcomes in offspring.

Sedatives in pregnancy and psychiatric outcomes in offspring.

Journal: BMJ (Clinical research ed.)

Published: April 29, 2026

Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors Among Patients with Type 1 Diabetes: A Nationwide Register-Based Cohort Study.

Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors Among Patients with Type 1 Diabetes: A Nationwide Register-Based Cohort Study.

Journal: The Lancet regional health. Europe

Published: March 13, 2026

Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case-control study.

Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case-control study.

Journal: The lancet. Diabetes & endocrinology

Published: February 23, 2026

Initiation of eplerenone vs. spironolactone and all-cause mortality in HFrEF: linked database study.

Initiation of eplerenone vs. spironolactone and all-cause mortality in HFrEF: linked database study.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: January 06, 2026

Trends in antipsychotic drug utilisation and indication in the paediatric population: a nationwide cohort study in Sweden.

Trends in antipsychotic drug utilisation and indication in the paediatric population: a nationwide cohort study in Sweden.

Journal: BMJ mental health

Published: December 30, 2025

Use of Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study.

Use of Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study.

Journal: Diabetes, obesity & metabolism

Published: December 19, 2025

Utilization patterns and determinants of guideline-recommended therapies for acute heart failure in Denmark.

Utilization patterns and determinants of guideline-recommended therapies for acute heart failure in Denmark.

Journal: European heart journal. Acute cardiovascular care

Published: August 07, 2025

Initiation of SGLT2 inhibitors versus mineralocorticoid receptor antagonists as third-line therapy in heart failure with reduced ejection fraction: a nationwide cohort study.

Initiation of SGLT2 inhibitors versus mineralocorticoid receptor antagonists as third-line therapy in heart failure with reduced ejection fraction: a nationwide cohort study.

Journal: The Lancet regional health. Europe

Published: July 21, 2025

Angiotensin Receptor-Neprilysin Inhibitors and Mortality Among Patients With HFrEF.

Angiotensin Receptor-Neprilysin Inhibitors and Mortality Among Patients With HFrEF.

Journal: The American journal of cardiology

Published: May 20, 2025

SGLT2 Inhibitors and Serious Renal Events Among Patients With Heart Failure With Reduced Ejection Fraction.

SGLT2 Inhibitors and Serious Renal Events Among Patients With Heart Failure With Reduced Ejection Fraction.

Journal: JACC. Heart failure

Published: April 29, 2025

Showing 1-12 of 120

Last Updated: 09/26/2026